nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—ABCC10—Paclitaxel—ovarian cancer	0.226	0.388	CbGbCtD
Cytarabine—ABCC10—Docetaxel—ovarian cancer	0.163	0.28	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—ovarian cancer	0.122	0.209	CbGbCtD
Cytarabine—CYP3A4—Topotecan—ovarian cancer	0.0255	0.0437	CbGbCtD
Cytarabine—CYP3A4—Vinorelbine—ovarian cancer	0.018	0.0308	CbGbCtD
Cytarabine—CYP3A4—Paclitaxel—ovarian cancer	0.0126	0.0216	CbGbCtD
Cytarabine—POLD1—oviduct—ovarian cancer	0.012	0.0615	CbGeAlD
Cytarabine—CYP3A4—Docetaxel—ovarian cancer	0.00912	0.0156	CbGbCtD
Cytarabine—CYP3A4—Doxorubicin—ovarian cancer	0.0068	0.0117	CbGbCtD
Cytarabine—Lamivudine—NME2—ovarian cancer	0.00454	0.606	CrCbGaD
Cytarabine—DCTD—myometrium—ovarian cancer	0.0038	0.0194	CbGeAlD
Cytarabine—POLB—uterine cervix—ovarian cancer	0.00367	0.0188	CbGeAlD
Cytarabine—POLB—decidua—ovarian cancer	0.00349	0.0179	CbGeAlD
Cytarabine—POLA1—Vinblastine—Vinorelbine—ovarian cancer	0.00317	0.675	CbGdCrCtD
Cytarabine—POLB—gonad—ovarian cancer	0.00308	0.0157	CbGeAlD
Cytarabine—POLD1—uterine cervix—ovarian cancer	0.003	0.0153	CbGeAlD
Cytarabine—DCTD—uterine cervix—ovarian cancer	0.00296	0.0151	CbGeAlD
Cytarabine—NT5E—myometrium—ovarian cancer	0.00294	0.015	CbGeAlD
Cytarabine—POLE—myometrium—ovarian cancer	0.00288	0.0147	CbGeAlD
Cytarabine—NT5E—embryo—ovarian cancer	0.00283	0.0145	CbGeAlD
Cytarabine—DCTD—decidua—ovarian cancer	0.00282	0.0144	CbGeAlD
Cytarabine—POLE—embryo—ovarian cancer	0.00277	0.0142	CbGeAlD
Cytarabine—POLB—female reproductive system—ovarian cancer	0.00275	0.014	CbGeAlD
Cytarabine—CDA—uterine cervix—ovarian cancer	0.00269	0.0138	CbGeAlD
Cytarabine—DCTD—endometrium—ovarian cancer	0.00267	0.0137	CbGeAlD
Cytarabine—POLB—bone marrow—ovarian cancer	0.00259	0.0133	CbGeAlD
Cytarabine—CDA—decidua—ovarian cancer	0.00256	0.0131	CbGeAlD
Cytarabine—POLD1—gonad—ovarian cancer	0.00251	0.0129	CbGeAlD
Cytarabine—POLB—female gonad—ovarian cancer	0.0025	0.0128	CbGeAlD
Cytarabine—POLD1—uterus—ovarian cancer	0.0025	0.0128	CbGeAlD
Cytarabine—POLB—vagina—ovarian cancer	0.00249	0.0127	CbGeAlD
Cytarabine—POLA1—myometrium—ovarian cancer	0.00248	0.0127	CbGeAlD
Cytarabine—DCTD—gonad—ovarian cancer	0.00248	0.0127	CbGeAlD
Cytarabine—DCTD—uterus—ovarian cancer	0.00246	0.0126	CbGeAlD
Cytarabine—CDA—endometrium—ovarian cancer	0.00243	0.0124	CbGeAlD
Cytarabine—NT5E—epithelium—ovarian cancer	0.00231	0.0118	CbGeAlD
Cytarabine—NT5E—uterine cervix—ovarian cancer	0.00229	0.0117	CbGeAlD
Cytarabine—POLD1—female reproductive system—ovarian cancer	0.00225	0.0115	CbGeAlD
Cytarabine—POLE—uterine cervix—ovarian cancer	0.00224	0.0115	CbGeAlD
Cytarabine—POLB—testis—ovarian cancer	0.00222	0.0113	CbGeAlD
Cytarabine—DCTD—female reproductive system—ovarian cancer	0.00221	0.0113	CbGeAlD
Cytarabine—NT5E—decidua—ovarian cancer	0.00218	0.0111	CbGeAlD
Cytarabine—POLE—decidua—ovarian cancer	0.00213	0.0109	CbGeAlD
Cytarabine—DCTD—bone marrow—ovarian cancer	0.00209	0.0107	CbGeAlD
Cytarabine—NT5E—endometrium—ovarian cancer	0.00207	0.0106	CbGeAlD
Cytarabine—POLD1—female gonad—ovarian cancer	0.00204	0.0104	CbGeAlD
Cytarabine—POLE—endometrium—ovarian cancer	0.00203	0.0104	CbGeAlD
Cytarabine—DCTD—female gonad—ovarian cancer	0.00202	0.0103	CbGeAlD
Cytarabine—DCTD—vagina—ovarian cancer	0.002	0.0102	CbGeAlD
Cytarabine—POLA1—uterine cervix—ovarian cancer	0.00193	0.00987	CbGeAlD
Cytarabine—NT5E—gonad—ovarian cancer	0.00192	0.00981	CbGeAlD
Cytarabine—NT5E—uterus—ovarian cancer	0.00191	0.00974	CbGeAlD
Cytarabine—CDA—bone marrow—ovarian cancer	0.0019	0.00973	CbGeAlD
Cytarabine—POLE—gonad—ovarian cancer	0.00188	0.00961	CbGeAlD
Cytarabine—POLA1—decidua—ovarian cancer	0.00184	0.00941	CbGeAlD
Cytarabine—CDA—vagina—ovarian cancer	0.00182	0.00932	CbGeAlD
Cytarabine—POLD1—testis—ovarian cancer	0.00181	0.00926	CbGeAlD
Cytarabine—DCTD—testis—ovarian cancer	0.00179	0.00914	CbGeAlD
Cytarabine—POLA1—endometrium—ovarian cancer	0.00175	0.00893	CbGeAlD
Cytarabine—NT5E—female reproductive system—ovarian cancer	0.00171	0.00876	CbGeAlD
Cytarabine—POLE—female reproductive system—ovarian cancer	0.00168	0.00858	CbGeAlD
Cytarabine—CDA—testis—ovarian cancer	0.00163	0.00831	CbGeAlD
Cytarabine—NT5E—bone marrow—ovarian cancer	0.00162	0.00827	CbGeAlD
Cytarabine—POLB—lymph node—ovarian cancer	0.00161	0.00822	CbGeAlD
Cytarabine—SLC29A1—myometrium—ovarian cancer	0.0016	0.00819	CbGeAlD
Cytarabine—POLE—bone marrow—ovarian cancer	0.00158	0.0081	CbGeAlD
Cytarabine—NT5E—female gonad—ovarian cancer	0.00156	0.00797	CbGeAlD
Cytarabine—NT5E—vagina—ovarian cancer	0.00155	0.00792	CbGeAlD
Cytarabine—DCK—myometrium—ovarian cancer	0.00153	0.00782	CbGeAlD
Cytarabine—POLE—female gonad—ovarian cancer	0.00153	0.00781	CbGeAlD
Cytarabine—POLE—vagina—ovarian cancer	0.00152	0.00776	CbGeAlD
Cytarabine—DCK—embryo—ovarian cancer	0.00147	0.00752	CbGeAlD
Cytarabine—ABCC10—myometrium—ovarian cancer	0.00146	0.00745	CbGeAlD
Cytarabine—NT5E—testis—ovarian cancer	0.00138	0.00707	CbGeAlD
Cytarabine—POLA1—bone marrow—ovarian cancer	0.00137	0.00698	CbGeAlD
Cytarabine—POLE—testis—ovarian cancer	0.00135	0.00693	CbGeAlD
Cytarabine—Glucosamine—MMP9—ovarian cancer	0.00132	0.177	CrCbGaD
Cytarabine—POLA1—female gonad—ovarian cancer	0.00132	0.00673	CbGeAlD
Cytarabine—POLD1—lymph node—ovarian cancer	0.00131	0.00672	CbGeAlD
Cytarabine—POLA1—vagina—ovarian cancer	0.00131	0.00669	CbGeAlD
Cytarabine—DCTD—lymph node—ovarian cancer	0.0013	0.00662	CbGeAlD
Cytarabine—SLC29A1—uterine cervix—ovarian cancer	0.00125	0.00637	CbGeAlD
Cytarabine—DCK—uterine cervix—ovarian cancer	0.00119	0.00609	CbGeAlD
Cytarabine—SLC29A1—decidua—ovarian cancer	0.00119	0.00607	CbGeAlD
Cytarabine—CDA—lymph node—ovarian cancer	0.00118	0.00603	CbGeAlD
Cytarabine—POLA1—testis—ovarian cancer	0.00117	0.00597	CbGeAlD
Cytarabine—DCK—decidua—ovarian cancer	0.00113	0.0058	CbGeAlD
Cytarabine—ABCC10—uterine cervix—ovarian cancer	0.00113	0.0058	CbGeAlD
Cytarabine—SLC29A1—endometrium—ovarian cancer	0.00113	0.00576	CbGeAlD
Cytarabine—Gemcitabine—TYMS—ovarian cancer	0.0011	0.147	CrCbGaD
Cytarabine—ABCC10—decidua—ovarian cancer	0.00108	0.00553	CbGeAlD
Cytarabine—DCK—endometrium—ovarian cancer	0.00108	0.00551	CbGeAlD
Cytarabine—SLC29A1—gonad—ovarian cancer	0.00105	0.00535	CbGeAlD
Cytarabine—SLC29A1—uterus—ovarian cancer	0.00104	0.00531	CbGeAlD
Cytarabine—ABCC10—endometrium—ovarian cancer	0.00103	0.00525	CbGeAlD
Cytarabine—NT5E—lymph node—ovarian cancer	0.001	0.00512	CbGeAlD
Cytarabine—DCK—gonad—ovarian cancer	0.000999	0.00511	CbGeAlD
Cytarabine—DCK—uterus—ovarian cancer	0.000992	0.00507	CbGeAlD
Cytarabine—POLE—lymph node—ovarian cancer	0.000982	0.00502	CbGeAlD
Cytarabine—ABCC10—gonad—ovarian cancer	0.000952	0.00487	CbGeAlD
Cytarabine—ABCC10—uterus—ovarian cancer	0.000945	0.00483	CbGeAlD
Cytarabine—SLC29A1—female reproductive system—ovarian cancer	0.000934	0.00477	CbGeAlD
Cytarabine—DCK—female reproductive system—ovarian cancer	0.000892	0.00456	CbGeAlD
Cytarabine—SLC29A1—bone marrow—ovarian cancer	0.000881	0.00451	CbGeAlD
Cytarabine—ABCC10—female reproductive system—ovarian cancer	0.00085	0.00434	CbGeAlD
Cytarabine—SLC29A1—female gonad—ovarian cancer	0.00085	0.00434	CbGeAlD
Cytarabine—POLA1—lymph node—ovarian cancer	0.000846	0.00433	CbGeAlD
Cytarabine—SLC29A1—vagina—ovarian cancer	0.000844	0.00432	CbGeAlD
Cytarabine—DCK—bone marrow—ovarian cancer	0.000842	0.00431	CbGeAlD
Cytarabine—DCK—female gonad—ovarian cancer	0.000812	0.00415	CbGeAlD
Cytarabine—DCK—vagina—ovarian cancer	0.000807	0.00412	CbGeAlD
Cytarabine—ABCC10—bone marrow—ovarian cancer	0.000802	0.0041	CbGeAlD
Cytarabine—DCK—Doxorubicin—Epirubicin—ovarian cancer	0.000792	0.169	CbGdCrCtD
Cytarabine—ABCC10—female gonad—ovarian cancer	0.000773	0.00395	CbGeAlD
Cytarabine—ABCC10—vagina—ovarian cancer	0.000769	0.00393	CbGeAlD
Cytarabine—SLC29A1—testis—ovarian cancer	0.000754	0.00385	CbGeAlD
Cytarabine—DCK—Epirubicin—Doxorubicin—ovarian cancer	0.000732	0.156	CbGdCrCtD
Cytarabine—DCK—testis—ovarian cancer	0.00072	0.00368	CbGeAlD
Cytarabine—SLC22A1—vagina—ovarian cancer	0.000688	0.00352	CbGeAlD
Cytarabine—ABCC10—testis—ovarian cancer	0.000686	0.00351	CbGeAlD
Cytarabine—SLC29A1—lymph node—ovarian cancer	0.000546	0.00279	CbGeAlD
Cytarabine—DCK—lymph node—ovarian cancer	0.000522	0.00267	CbGeAlD
Cytarabine—ABCC10—lymph node—ovarian cancer	0.000497	0.00254	CbGeAlD
Cytarabine—CYP3A4—female reproductive system—ovarian cancer	0.000347	0.00177	CbGeAlD
Cytarabine—Gemcitabine—ABCB1—ovarian cancer	0.000278	0.0372	CrCbGaD
Cytarabine—Lamivudine—ABCB1—ovarian cancer	0.000253	0.0338	CrCbGaD
Cytarabine—POLE—Cell Cycle—BRCA1—ovarian cancer	0.000107	0.00051	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000106	0.000508	CbGpPWpGaD
Cytarabine—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000106	0.000508	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000105	0.000503	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000104	0.0005	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—PPP2R1A—ovarian cancer	0.000104	0.000498	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TYMS—ovarian cancer	0.000103	0.000491	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—BRIP1—ovarian cancer	0.000101	0.000485	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPP1CC—ovarian cancer	0.000101	0.000485	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CAV1—ovarian cancer	0.000101	0.000483	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—PPP2R1A—ovarian cancer	0.000101	0.000481	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.0001	0.00048	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MLH1—ovarian cancer	0.0001	0.00048	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BRCA2—ovarian cancer	9.98e-05	0.000478	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—SKP2—ovarian cancer	9.91e-05	0.000474	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.91e-05	0.000474	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—FASN—ovarian cancer	9.76e-05	0.000467	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCNE1—ovarian cancer	9.67e-05	0.000463	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BRCA2—ovarian cancer	9.64e-05	0.000461	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SLC5A5—ovarian cancer	9.6e-05	0.00046	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.55e-05	0.000457	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—ovarian cancer	9.55e-05	0.000457	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPP1CC—ovarian cancer	9.52e-05	0.000456	CbGpPWpGaD
Cytarabine—DCK—Metabolism—BRIP1—ovarian cancer	9.52e-05	0.000456	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TYMS—ovarian cancer	9.49e-05	0.000454	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	9.39e-05	0.00045	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCNE1—ovarian cancer	9.34e-05	0.000447	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SLC2A1—ovarian cancer	9.27e-05	0.000444	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.22e-05	0.000441	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CG—ovarian cancer	9.19e-05	0.00044	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TYMS—ovarian cancer	9.17e-05	0.000439	CbGpPWpGaD
Cytarabine—CDA—Metabolism—FASN—ovarian cancer	8.93e-05	0.000427	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CYP1B1—ovarian cancer	8.89e-05	0.000426	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—ovarian cancer	8.78e-05	0.000421	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC5A5—ovarian cancer	8.78e-05	0.00042	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—ovarian cancer	8.67e-05	0.000415	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	8.6e-05	0.000412	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	8.58e-05	0.000411	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—AQP3—ovarian cancer	8.56e-05	0.00041	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BIRC5—ovarian cancer	8.54e-05	0.000409	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	8.52e-05	0.000408	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND2—ovarian cancer	8.49e-05	0.000407	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC2A1—ovarian cancer	8.48e-05	0.000406	CbGpPWpGaD
Cytarabine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	8.47e-05	0.000405	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TERT—ovarian cancer	8.27e-05	0.000396	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BIRC5—ovarian cancer	8.24e-05	0.000395	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	8.23e-05	0.000394	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	8.21e-05	0.000393	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CYP1B1—ovarian cancer	8.13e-05	0.000389	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CHEK2—ovarian cancer	8.1e-05	0.000388	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CD—ovarian cancer	8.08e-05	0.000387	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—ovarian cancer	8.05e-05	0.000385	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	8.01e-05	0.000384	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TERT—ovarian cancer	7.99e-05	0.000382	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—AQP3—ovarian cancer	7.98e-05	0.000382	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	7.97e-05	0.000381	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	7.94e-05	0.00038	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPP2R1A—ovarian cancer	7.88e-05	0.000377	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	7.81e-05	0.000374	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	7.67e-05	0.000367	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.65e-05	0.000366	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	7.6e-05	0.000364	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND2—ovarian cancer	7.59e-05	0.000364	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BRCA1—ovarian cancer	7.59e-05	0.000364	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	7.53e-05	0.00036	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCNE1—ovarian cancer	7.44e-05	0.000356	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	7.33e-05	0.000351	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ABCB1—ovarian cancer	7.32e-05	0.00035	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TYMS—ovarian cancer	7.31e-05	0.00035	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPP2R1A—ovarian cancer	7.21e-05	0.000345	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMS—ovarian cancer	7.19e-05	0.000344	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—PPP2R1A—ovarian cancer	7.16e-05	0.000343	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CB—ovarian cancer	7.04e-05	0.000337	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.96e-05	0.000333	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BRCA2—ovarian cancer	6.87e-05	0.000329	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—YAP1—ovarian cancer	6.79e-05	0.000325	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ABCB1—ovarian cancer	6.69e-05	0.00032	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NME2—ovarian cancer	6.69e-05	0.00032	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCNE1—ovarian cancer	6.65e-05	0.000318	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	6.62e-05	0.000317	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMS—ovarian cancer	6.58e-05	0.000315	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—BIRC5—ovarian cancer	6.57e-05	0.000315	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TYMS—ovarian cancer	6.53e-05	0.000313	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.49e-05	0.000311	CbGpPWpGaD
Cytarabine—DCK—Metabolism—YAP1—ovarian cancer	6.39e-05	0.000306	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	6.27e-05	0.0003	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NME2—ovarian cancer	6.24e-05	0.000299	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	6.1e-05	0.000292	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—ovarian cancer	6.08e-05	0.000291	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	6.05e-05	0.00029	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	5.96e-05	0.000285	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	5.96e-05	0.000285	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BIRC5—ovarian cancer	5.87e-05	0.000281	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CAV1—ovarian cancer	5.79e-05	0.000277	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	5.69e-05	0.000273	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TERT—ovarian cancer	5.69e-05	0.000272	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	5.63e-05	0.00027	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.6e-05	0.000268	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—FASN—ovarian cancer	5.54e-05	0.000265	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC5A5—ovarian cancer	5.45e-05	0.000261	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	5.42e-05	0.000259	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.41e-05	0.000259	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.35e-05	0.000256	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CAV1—ovarian cancer	5.3e-05	0.000254	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CG—ovarian cancer	5.28e-05	0.000253	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC2A1—ovarian cancer	5.26e-05	0.000252	CbGpPWpGaD
Cytarabine—DCK—Metabolism—FASN—ovarian cancer	5.21e-05	0.000249	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	5.17e-05	0.000248	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.16e-05	0.000247	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC5A5—ovarian cancer	5.12e-05	0.000245	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CYP1B1—ovarian cancer	5.04e-05	0.000241	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1B—ovarian cancer	5.01e-05	0.00024	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	5.01e-05	0.00024	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC2A1—ovarian cancer	4.95e-05	0.000237	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1B—ovarian cancer	4.84e-05	0.000232	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CG—ovarian cancer	4.83e-05	0.000231	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—ovarian cancer	4.78e-05	0.000229	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CYP1B1—ovarian cancer	4.74e-05	0.000227	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CD—ovarian cancer	4.64e-05	0.000222	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—ovarian cancer	4.62e-05	0.000221	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPP2R1A—ovarian cancer	4.47e-05	0.000214	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.41e-05	0.000211	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.33e-05	0.000207	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYTB—ovarian cancer	4.31e-05	0.000207	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—ovarian cancer	4.29e-05	0.000205	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—ovarian cancer	4.29e-05	0.000205	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.26e-05	0.000204	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CD—ovarian cancer	4.24e-05	0.000203	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	4.23e-05	0.000202	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPP2R1A—ovarian cancer	4.2e-05	0.000201	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.19e-05	0.000201	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.18e-05	0.0002	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ABCB1—ovarian cancer	4.15e-05	0.000199	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—ovarian cancer	4.14e-05	0.000198	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMS—ovarian cancer	4.08e-05	0.000195	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—ovarian cancer	4.06e-05	0.000194	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.05e-05	0.000194	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CB—ovarian cancer	4.04e-05	0.000194	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.04e-05	0.000193	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYTB—ovarian cancer	4.02e-05	0.000192	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MAPK3—ovarian cancer	3.94e-05	0.000189	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ABCB1—ovarian cancer	3.9e-05	0.000187	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.9e-05	0.000187	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—ovarian cancer	3.86e-05	0.000185	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.86e-05	0.000185	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMS—ovarian cancer	3.83e-05	0.000184	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—ovarian cancer	3.83e-05	0.000184	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MAPK3—ovarian cancer	3.81e-05	0.000182	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPP1CC—ovarian cancer	3.77e-05	0.000181	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—BRIP1—ovarian cancer	3.77e-05	0.000181	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MAPK1—ovarian cancer	3.75e-05	0.00018	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—ovarian cancer	3.7e-05	0.000177	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CB—ovarian cancer	3.7e-05	0.000177	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.7e-05	0.000177	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.68e-05	0.000176	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.64e-05	0.000174	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MAPK1—ovarian cancer	3.62e-05	0.000173	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—BRIP1—ovarian cancer	3.51e-05	0.000168	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPP1CC—ovarian cancer	3.51e-05	0.000168	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—ovarian cancer	3.51e-05	0.000168	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—ovarian cancer	3.49e-05	0.000167	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1B—ovarian cancer	3.45e-05	0.000165	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.3e-05	0.000158	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—ovarian cancer	3.29e-05	0.000157	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CAV1—ovarian cancer	3.29e-05	0.000157	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—ovarian cancer	3.2e-05	0.000153	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—ovarian cancer	3.15e-05	0.000151	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	3.11e-05	0.000149	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CAV1—ovarian cancer	3.09e-05	0.000148	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.08e-05	0.000147	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—ovarian cancer	3.04e-05	0.000146	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK3—ovarian cancer	3.03e-05	0.000145	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CG—ovarian cancer	2.99e-05	0.000143	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—ovarian cancer	2.95e-05	0.000141	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	2.9e-05	0.000139	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.89e-05	0.000138	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CG—ovarian cancer	2.81e-05	0.000135	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK3—ovarian cancer	2.71e-05	0.00013	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—ovarian cancer	2.64e-05	0.000126	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CD—ovarian cancer	2.63e-05	0.000126	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MAPK1—ovarian cancer	2.58e-05	0.000124	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—YAP1—ovarian cancer	2.53e-05	0.000121	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.5e-05	0.00012	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CD—ovarian cancer	2.47e-05	0.000118	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—ovarian cancer	2.46e-05	0.000118	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—MAPK1—ovarian cancer	2.38e-05	0.000114	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—YAP1—ovarian cancer	2.36e-05	0.000113	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—ovarian cancer	2.33e-05	0.000111	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CB—ovarian cancer	2.29e-05	0.00011	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—ovarian cancer	2.25e-05	0.000108	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NME2—ovarian cancer	2.25e-05	0.000108	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—MAPK1—ovarian cancer	2.22e-05	0.000106	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—ovarian cancer	2.17e-05	0.000104	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CB—ovarian cancer	2.16e-05	0.000103	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—FASN—ovarian cancer	2.06e-05	9.87e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC5A5—ovarian cancer	2.03e-05	9.71e-05	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—ovarian cancer	2.01e-05	9.64e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—ovarian cancer	1.98e-05	9.49e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC2A1—ovarian cancer	1.96e-05	9.38e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—FASN—ovarian cancer	1.92e-05	9.2e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—ovarian cancer	1.91e-05	9.16e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC5A5—ovarian cancer	1.89e-05	9.05e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CYP1B1—ovarian cancer	1.88e-05	8.99e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—ovarian cancer	1.86e-05	8.92e-05	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—ovarian cancer	1.84e-05	8.82e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC2A1—ovarian cancer	1.83e-05	8.74e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—ovarian cancer	1.78e-05	8.54e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CYP1B1—ovarian cancer	1.75e-05	8.38e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPP2R1A—ovarian cancer	1.67e-05	7.97e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPP2R1A—ovarian cancer	1.55e-05	7.43e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ABCB1—ovarian cancer	1.55e-05	7.4e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—ovarian cancer	1.52e-05	7.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYTB—ovarian cancer	1.45e-05	6.95e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ABCB1—ovarian cancer	1.44e-05	6.9e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—ovarian cancer	1.42e-05	6.78e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—ovarian cancer	1.4e-05	6.69e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—ovarian cancer	1.31e-05	6.29e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.27e-05	6.08e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.27e-05	6.08e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CAV1—ovarian cancer	1.22e-05	5.86e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—ovarian cancer	1.14e-05	5.47e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CAV1—ovarian cancer	1.14e-05	5.46e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CG—ovarian cancer	1.11e-05	5.34e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—ovarian cancer	1.07e-05	5.14e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CG—ovarian cancer	1.04e-05	4.97e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CD—ovarian cancer	9.8e-06	4.69e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CD—ovarian cancer	9.13e-06	4.37e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CB—ovarian cancer	8.54e-06	4.09e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—YAP1—ovarian cancer	8.51e-06	4.08e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CB—ovarian cancer	7.96e-06	3.81e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—ovarian cancer	7.38e-06	3.53e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—FASN—ovarian cancer	6.94e-06	3.32e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—ovarian cancer	6.88e-06	3.29e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.83e-06	3.27e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.59e-06	3.16e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	6.32e-06	3.03e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.61e-06	2.68e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—ovarian cancer	5.21e-06	2.49e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.2e-06	2.49e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—ovarian cancer	5.11e-06	2.45e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	4.85e-06	2.32e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—ovarian cancer	4.25e-06	2.04e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CAV1—ovarian cancer	4.12e-06	1.97e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—ovarian cancer	3.96e-06	1.9e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.75e-06	1.8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.3e-06	1.58e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.87e-06	1.38e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—ovarian cancer	2.48e-06	1.19e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.75e-06	8.39e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—ovarian cancer	1.43e-06	6.85e-06	CbGpPWpGaD
